Immuneering - Class A (IMRX)'s 30-day implied volatility (IV30) was 69.4% at the close on November 2, 2026, up from 68.1% the day before, against a 52-week range of 46.0% to 221.8%. Its 20-day historical volatility was 54.8%.
Data as of November 2, 2026.